Here's what traders are watching as we get closer to the first presidential debate on Monday.
Investors cheered no rate hike from the Fed, but there's more than meets the eye to today's rally.
Some of the names on the move ahead of the open.
NEW YORK— Rite Aid Corp. on Thursday reported a drop in fiscal second-quarter profit as higher costs weighed down a boost in revenue. Walgreens Boots Alliance Inc. is in the process of buying Rite Aid for $9.41 billion. Camp Hill, Pennsylvania- based Rite Aid said its profit dropped 31 percent to $14.8 million, or 1 cent per share.
After the Fed leaves rates unchanged, traders wonder what's really keeping rates on hold.
After many false starts, we're finally starting to see the IPO market gain ground in September.
Jim Cramer shares his game plan of stocks and events on his radar next week, including the anticipated Federal Reserve meeting.
We may have had a data deluge today, but right now this rally is all about Apple.
Apple's rally is about more than just Samsung's battery woes. There may be more to the iPhone 7 than meets the eye.
Stocks have gone on a roller coaster ride from Friday through today alone.
Boston Fed President Eric Rosengren has reminded everyone the markets are not positioned for a September rate hike.
Reflecting on 9/11, the ripple effects and signs of new life downtown 15 years later.
With markets hovering at new highs, here's why traders are growing desperate.
Markets are steady as she goes with strength in two key sectors.
Jim Cramer advised investors how to prepare for the worst ahead of the next rate hike.
Jim Cramer advises investors on how to prepare for the worst ahead of the next rate hike.
A year ago, Theranos founder Elizabeth Holmes was one of the darlings of Silicon Valley before praise for her blood-testing company turned to criticism.
"Power Lunch" hosts Melissa Lee and Brian Sullivan look at 5 stocks with analyst recommendations, including Walgreens and Twitter.
Express Scripts said it will implement a program that guarantees spending caps on diabetes drug costs.
Yellen and Fischer's comments at Jackson Hole leave markets right where they started the session.